Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005.

被引：0
|
作者：
Neukirchen, Judith [1 ]
Schoonen, W. Marieke [2 ]
Aul, Carlo [3 ]
Haas, Rainer [1 ]
Gattermann, Norbert [1 ]
Germing, Ulrich [1 ]
机构：
[1] Univ Dusseldorf, Dusseldorf, Germany
[2] Amgen Ltd, Cambridge, England
[3] St Johannes Hosp, Med Clin 2, Duisburg, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：705 / 706
页数：2
相关论文
共 50 条
  • [31] Influence of different treatment strategies on the prognosis of patients with myelodysplastic syndromes (MDS)
    Nachtkamp, K.
    Kuendgen, A.
    Strupp, C.
    Gattermann, N.
    Giagounidis, A.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2007, 31 : S30 - S30
  • [32] Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes (MDS).
    Yazji, S
    Giles, F
    Kantarjian, H
    Estey, E
    O'Brien, S
    Kurzrock, R
    BLOOD, 2002, 100 (11) : 794A - 794A
  • [33] Levels of circulating endothelial adhesion molecules in patients with myelodysplastic syndromes (MDS).
    Sudhoff, T
    Wehmeier, A
    Aul, C
    BLOOD, 1997, 90 (10) : 4051 - 4051
  • [34] A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Komrokji, Rami S.
    Barnard, John
    Al-Issa, Karam
    Padron, Eric
    Madanat, Yazan F.
    Kuzmanovic, Teodora
    Abuhadra, Nour
    Steensma, David P.
    DeZern, Amy E.
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    List, Alan F.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2017, 130
  • [35] Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group
    Kouraklis, A.
    Symeonidis, A.
    Galanopoulos, A.
    Kaiafa, G.
    Tavernarakis, I.
    Tsirakis, G.
    Michali, E.
    Tsaftaridis, P.
    Loukidis, K.
    Aggelidis, A.
    Zoumbos, N.
    LEUKEMIA RESEARCH, 2009, 33 : S119 - S120
  • [36] Genomic imbalances in 139 patients with myelodysplastic syndromes (MDS) and complex karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Buryova, Halka
    Kostylkova, Karla
    Bystricka, Dagmar
    Novakova, Milena
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Ransdorfova, Sarka
    Zmolikova, Jana
    Siskova, Magda
    Cermak, Jaroslav
    CHROMOSOME RESEARCH, 2013, 21 : S92 - S93
  • [37] GATA2-RELATED MYELODYSPLASTIC SYNDROMES (MDS): PREVALENCE, CLINICAL CHARACTERISTICS AND PROGNOSIS
    Wlodarski, M.
    Hirabayashi, S.
    Pastor, V.
    Stary, J.
    Hasle, H.
    Masetti, R.
    Dworzak, M.
    Schmugge, M.
    van den Heuvel-Eibrink, M.
    De Moerloose, B.
    Ussowicz, M.
    Catala, A.
    Smith, O.
    Goehring, G.
    Schlegelberger, B.
    Locatelli, F.
    Makishima, H.
    Maciejewski, J.
    Strahm, B.
    Niemeyer, C.
    LEUKEMIA RESEARCH, 2015, 39 : S22 - S22
  • [38] Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
    Plesnila-Frank, C.
    Berger, K.
    Vioni-Niemeyer, A.
    Schramm, W.
    LEUKEMIA RESEARCH, 2007, 31 : S112 - S112
  • [39] Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
    Plesnila-Frank, C.
    Rottenkolber, D.
    Berger, K.
    VALUE IN HEALTH, 2007, 10 (06) : A283 - A284
  • [40] The clinical significance or apoptosis in the marrow of patients with primary myelodysplastic syndromes (MDS)
    Kouraklis, A
    Tsoplou, P
    Symeonidis, A
    Orphanos, V
    Zoumbos, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 263 - 263
12345